Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Rezolute Inc (RZLT)

Rezolute Inc (RZLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 255,529
  • Shares Outstanding, K 57,943
  • Annual Sales, $ 0 K
  • Annual Income, $ -68,460 K
  • EBIT $ -71 M
  • EBITDA $ -74 M
  • 60-Month Beta 1.01
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.19

Options Overview Details

View History
  • Implied Volatility 75.74% ( -161.99%)
  • Historical Volatility 64.86%
  • IV Percentile 38%
  • IV Rank 18.24%
  • IV High 359.75% on 08/30/24
  • IV Low 12.39% on 09/24/24
  • Put/Call Vol Ratio 0.03
  • Today's Volume 30
  • Volume Avg (30-Day) 19
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 4,609
  • Open Int (30-Day) 4,703

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.25
  • Number of Estimates 3
  • High Estimate -0.24
  • Low Estimate -0.26
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +7.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.07 +23.10%
on 12/18/24
5.53 -9.40%
on 12/03/24
+0.22 (+4.59%)
since 11/26/24
3-Month
4.07 +23.10%
on 12/18/24
6.19 -19.01%
on 11/11/24
+0.13 (+2.66%)
since 09/26/24
52-Week
0.90 +456.67%
on 01/17/24
6.19 -19.01%
on 11/11/24
+4.11 (+456.67%)
since 12/26/23

Most Recent Stories

More News
3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying

The year 2024 has been a mixed ride for the biotech industry. It started on a positive note, attracting investors’ attention in areas with great commercial potential, like obesity, immunology and gene...

ALLO : 2.17 (+3.83%)
RZLT : 5.01 (+13.61%)
VNDA : 4.81 (-0.41%)
Insider Purchase: CFO of $RZLT (RZLT) Buys 9,000 Shares

Daron Evans, the CFO of $RZLT ($RZLT), bought 9,000 shares of the company on 12-12-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings...

RZLT : 5.01 (+13.61%)
Insider Purchase: CFO of $RZLT (RZLT) Buys 10,549 Shares

Daron Evans, the CFO of $RZLT ($RZLT), bought 10,549 shares of the company on 12-09-2025. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings...

RZLT : 5.01 (+13.61%)
Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

RZLT : 5.01 (+13.61%)
RZLT Stock Rises on FDA's Orphan Designation for Rare Disease Drug

Rezolute, Inc. RZLT announced that the FDA has granted an Orphan Drug Designation (“ODD”) to its lead pipeline candidate, ersodetug (RZ358), for the treatment of hypoglycemia caused by tumor hyperinsulinism...

IMCR : 30.22 (+5.44%)
RZLT : 5.01 (+13.61%)
CSTL : 27.10 (-2.24%)
SPRO : 0.9439 (+0.68%)
FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

RZLT : 5.01 (+13.61%)
Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update

RZLT : 5.01 (+13.61%)
Rezolute to Participate in Upcoming Investor Conferences

RZLT : 5.01 (+13.61%)
5 Biotech Stocks Under $10 With Multibagger Potential

As the biotech industry continues to redefine the healthcare landscape, here are five penny biotech stocks poised for meteoric growth in this evolving industry.

ADCT : 2.12 (+4.43%)
$SPX : 6,037.59 (-0.04%)
RZLT : 5.01 (+13.61%)
TRVI : 4.21 (+5.25%)
ELEV : 0.5936 (+5.27%)
CRDL : 1.3200 (+4.76%)
S&P Futures Tick Lower Ahead of FOMC Meeting Minutes, Nvidia Earnings in Focus

June S&P 500 E-Mini futures (ESM24) are trending down -0.11% this morning as market participants awaited minutes of the Federal Reserve’s latest policy meeting as well as an earnings report from artificial...

ESM24 : 5,471.89s (-0.09%)
FSLR : 183.71 (-1.34%)
TSLA : 454.13 (-1.76%)
IBM : 224.89 (+0.21%)
NDSN : 213.30 (+0.48%)
PANW : 188.50 (-0.53%)
NVDA : 139.93 (-0.21%)
TJX : 125.01 (+1.23%)
ADI : 218.06 (-0.01%)
TGT : 136.39 (+3.01%)
SNOW : 163.48 (+0.26%)
MKS.LN : 381.800 (+0.82%)

Business Summary

Rezolute, Inc. is a biopharmaceutical company specializing in the development of drug therapies for metabolic and orphan diseases. The Company's products include AB101, RZ358, RZ402 and RZ602 which are in clinical stage. Rezolute, Inc., formerly known as AntriaBio, Inc., is based in LOUISVILLE, United...

See More

Key Turning Points

3rd Resistance Point 6.02
2nd Resistance Point 5.55
1st Resistance Point 5.28
Last Price 5.01
1st Support Level 4.55
2nd Support Level 4.08
3rd Support Level 3.81

See More

52-Week High 6.19
Last Price 5.01
Fibonacci 61.8% 4.17
Fibonacci 50% 3.54
Fibonacci 38.2% 2.92
52-Week Low 0.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar